IART
Integra LifeSciences Holdings Corporation
Price Chart
Latest Quote
$17.78
+0.09 (+0.51%)
Current Price
| Previous Close | $17.69 |
| Open | $17.86 |
| Day High | $18.24 |
| Day Low | $17.66 |
| Volume | 577,761 |
Stock Information
| Shares Outstanding | 77.80M |
| Total Debt | $2.04B |
| Cash Equivalents | $265.50M |
| Revenue | $1.64B |
| Net Income | $-495.80M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.38B |
| EPS (TTM) | $-6.47 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.16B |
| Sales | $1.64B |
| Income | $-495.80M |
| Book/sh | $13.39 |
| Cash/sh | $3.41 |
| Employees | 4K |
Financial Ratios
| Quick Ratio | 1.53 |
| Current Ratio | 3.38 |
| Debt/Eq | 195.78 |
Returns & Margins
| ROA | 2.54% |
| ROE | -38.63% |
| Gross Margin | 56.72% |
| Operating Margin | 10.41% |
| Profit Margin | -30.15% |
Ownership
| Insider Ownership | 14.30% |
| Institutional Ownership | 101.15% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 6.79 |
| PEG | 0.67 |
| P/S | 0.84 |
| P/B | 1.33 |
Analyst Data
| Recommendation | hold |
| Target Price | $17.43 |
Technical Indicators
| SMA20 | $17.00 |
| SMA50 | $14.32 |
| SMA200 | $12.81 |
| RSI | 63.59 |
| ATR | 0.8407 |
| Shares Float | 58.69M |
| Short Float | 14.15% |
| Short Ratio | 6.39 |
| Volatility | 1.25 |
| Rel Volume | 0.75 |
Performance History
| Week | +0.40% |
| Month | +17.75% |
| Quarter | +86.37% |
| 6 Months | +40.55% |
| YTD | +48.04% |
| Year | +53.01% |
| 3 Years | -57.09% |
| 5 Years | -74.40% |
| 10 Years | -53.11% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $17.78 | 720,100 |
| 2026-06-23 | $17.69 | 860,600 |
| 2026-06-22 | $17.60 | 841,200 |
| 2026-06-18 | $17.58 | 2,322,900 |
| 2026-06-17 | $17.20 | 791,500 |
| 2026-06-16 | $17.71 | 862,000 |
| 2026-06-15 | $17.46 | 891,500 |
| 2026-06-12 | $17.77 | 534,400 |
| 2026-06-11 | $17.51 | 580,500 |
| 2026-06-10 | $17.09 | 692,000 |
| 2026-06-09 | $17.90 | 1,092,400 |
| 2026-06-08 | $16.94 | 927,800 |
| 2026-06-05 | $16.99 | 867,900 |
| 2026-06-04 | $17.56 | 984,900 |
| 2026-06-03 | $16.10 | 766,300 |
| 2026-06-02 | $15.67 | 1,143,200 |
| 2026-06-01 | $15.67 | 800,300 |
| 2026-05-29 | $16.04 | 1,197,200 |
| 2026-05-28 | $16.46 | 1,340,900 |
| 2026-05-27 | $15.19 | 894,700 |
| 2026-05-26 | $15.19 | 842,200 |
About Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
đ° Latest News
Zacks.com featured highlights TPG Mortgage Investment Trust, Silvercorp and Integra LifeSciences
Zacks âĸ 2026-06-24T08:34:00Z
Surgical Equipment & Consumables - Specialty Stocks Q1 Results: Benchmarking Integra LifeSciences (NASDAQ:IART)
StockStory âĸ 2026-06-23T16:16:46Z
Bet on These 3 Stocks as Broker Rating Upgrades Signal Upside
Zacks âĸ 2026-06-23T12:32:00ZIntegra (IART) Shows Fast-paced Momentum But Is Still a Bargain Stock
Zacks âĸ 2026-06-22T12:55:02Z
IART vs. SONVY: Which Stock Is the Better Value Option?
Zacks âĸ 2026-06-19T15:40:04Z
Stocks Supported as Geopolitical Risks Recede
Barchart âĸ 2026-06-18T15:17:09Z
Integra LifeSciences Holdings Corporation (IART) Hits Fresh High: Is There Still Room to Run?
Zacks âĸ 2026-06-16T13:15:03Z
3 Profitable Stocks Weâre Skeptical Of
StockStory âĸ 2026-06-15T09:56:07Z
Integra LifeSciences (IART) EPS Beat and Conference Push: What Does It Reveal About Managementâs Conviction?
Simply Wall St. âĸ 2026-06-06T02:12:35Z
3 Reasons to Avoid IART and 1 Stock to Buy Instead
StockStory âĸ 2026-06-05T21:52:14Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $666,747,000 | $608,863,000 | $545,702,000 | $482,938,000 |
| Cost Of Revenue | $803,625,000 | $728,466,000 | $656,838,000 | $587,355,000 |
| Total Revenue | $1,635,245,000 | $1,610,527,000 | $1,541,573,000 | $1,557,666,000 |
| Operating Revenue | $1,635,245,000 | $1,610,527,000 | $1,541,573,000 | $1,557,666,000 |
| Expenses | ||||
| Interest Expense | $86,255,000 | $70,632,000 | $51,377,000 | $49,594,000 |
| Total Expenses | $1,617,250,000 | $1,582,116,000 | $1,430,047,000 | $1,318,746,000 |
| Other Income Expense | $-513,716,000 | $3,944,000 | $3,718,000 | $12,651,000 |
| Other Non Operating Income Expenses | $-2,351,000 | $3,944,000 | $3,718,000 | $12,007,000 |
| Net Non Operating Interest Income Expense | $-67,781,000 | $-50,592,000 | $-34,175,000 | $-37,677,000 |
| Interest Expense Non Operating | $86,255,000 | $70,632,000 | $51,377,000 | $49,594,000 |
| Operating Expense | $813,625,000 | $853,650,000 | $773,209,000 | $731,391,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-516,474,000 | $-6,944,000 | $67,741,000 | $180,550,000 |
| Net Interest Income | $-67,781,000 | $-50,592,000 | $-34,175,000 | $-37,677,000 |
| Interest Income | $18,474,000 | $20,040,000 | $17,202,000 | $11,917,000 |
| Normalized Income | $-47,552,295 | $-6,944,000 | $67,741,000 | $180,006,464 |
| Net Income From Continuing And Discontinued Operation | $-516,474,000 | $-6,944,000 | $67,741,000 | $180,550,000 |
| Total Operating Income As Reported | $-493,370,000 | $28,411,000 | $111,526,000 | $238,920,000 |
| Net Income Common Stockholders | $-516,474,000 | $-6,944,000 | $67,741,000 | $180,550,000 |
| Net Income | $-516,474,000 | $-6,944,000 | $67,741,000 | $180,550,000 |
| Net Income Including Noncontrolling Interests | $-516,474,000 | $-6,944,000 | $67,741,000 | $180,550,000 |
| Net Income Continuous Operations | $-516,474,000 | $-6,944,000 | $67,741,000 | $180,550,000 |
| Pretax Income | $-563,502,000 | $-18,237,000 | $81,069,000 | $213,894,000 |
| Special Income Charges | $-511,365,000 | $0 | $0 | $644,000 |
| Interest Income Non Operating | $18,474,000 | $20,040,000 | $17,202,000 | $11,917,000 |
| Operating Income | $17,995,000 | $28,411,000 | $111,526,000 | $238,920,000 |
| Depreciation Amortization Depletion Income Statement | $14,954,000 | $21,290,000 | $12,376,000 | $13,882,000 |
| Depreciation And Amortization In Income Statement | $14,954,000 | $21,290,000 | $12,376,000 | $13,882,000 |
| Amortization Of Intangibles Income Statement | $14,954,000 | $21,290,000 | $12,376,000 | $13,882,000 |
| Gross Profit | $831,620,000 | $882,061,000 | $884,735,000 | $970,311,000 |
| Per Share | ||||
| Diluted EPS | $-6.74 | $-0.09 | $0.84 | $2.16 |
| Basic EPS | $-6.63 | $-0.09 | $0.87 | $2.16 |
| Other | ||||
| Tax Effect Of Unusual Items | $-42,443,295 | $0 | $0 | $100,464 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $185,950,000 | $193,288,000 | $255,958,000 | $381,143,000 |
| Total Unusual Items | $-511,365,000 | $0 | $0 | $644,000 |
| Total Unusual Items Excluding Goodwill | $-511,365,000 | $0 | $0 | $644,000 |
| Reconciled Depreciation | $151,832,000 | $140,893,000 | $123,512,000 | $118,299,000 |
| EBITDA (Bullshit earnings) | $-325,415,000 | $193,288,000 | $255,958,000 | $381,787,000 |
| EBIT | $-477,247,000 | $52,395,000 | $132,446,000 | $263,488,000 |
| Diluted Average Shares | $77,887,000 | $77,164,000 | $80,337,000 | $83,587,963 |
| Basic Average Shares | $77,887,000 | $77,164,000 | $78,169,000 | $83,587,963 |
| Diluted NI Availto Com Stockholders | $-516,474,000 | $-6,944,000 | $67,741,000 | $180,550,000 |
| Tax Provision | $-47,028,000 | $-11,293,000 | $13,328,000 | $33,344,000 |
| Impairment Of Capital Assets | $511,365,000 | $0 | $0 | - |
| Amortization | $14,954,000 | $21,290,000 | $12,376,000 | $13,882,000 |
| Research And Development | $98,971,000 | $115,377,000 | $104,192,000 | $101,193,000 |
| Selling General And Administration | $699,700,000 | $716,983,000 | $656,641,000 | $616,316,000 |
| Gain On Sale Of Business | - | $0 | $0 | $644,000 |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-706,357,000 | $-759,260,000 | $-535,411,000 | $-361,087,000 |
| Total Assets | $3,602,001,000 | $4,037,424,000 | $3,781,988,000 | $3,889,758,000 |
| Total Non Current Assets | $2,442,457,000 | $2,955,743,000 | $2,723,952,000 | $2,728,260,000 |
| Other Non Current Assets | $37,880,000 | $66,515,000 | $58,194,000 | $57,190,000 |
| Non Current Deferred Assets | $69,854,000 | $34,923,000 | $46,080,000 | $45,994,000 |
| Non Current Deferred Taxes Assets | $69,854,000 | $34,923,000 | $46,080,000 | $45,994,000 |
| Goodwill And Other Intangible Assets | $1,749,820,000 | $2,304,540,000 | $2,123,295,000 | $2,165,490,000 |
| Other Intangible Assets | $1,134,663,000 | $1,207,588,000 | $1,067,833,000 | $1,126,609,000 |
| Current Assets | $1,159,544,000 | $1,081,681,000 | $1,058,036,000 | $1,161,498,000 |
| Other Current Assets | $28,130,000 | $29,653,000 | $32,643,000 | $31,032,000 |
| Prepaid Assets | $96,089,000 | $77,001,000 | $67,362,000 | $85,757,000 |
| Inventory | $492,735,000 | $429,090,000 | $389,608,000 | $324,583,000 |
| Receivables | $278,849,000 | $272,370,000 | $259,327,000 | $263,465,000 |
| Accounts Receivable | $278,849,000 | $272,370,000 | $259,327,000 | $263,465,000 |
| Allowance For Doubtful Accounts Receivable | $-7,230,000 | $-6,917,000 | $-4,879,000 | $-4,304,000 |
| Gross Accounts Receivable | $286,079,000 | $279,287,000 | $264,206,000 | $267,769,000 |
| Cash Cash Equivalents And Short Term Investments | $263,741,000 | $273,567,000 | $309,096,000 | $456,661,000 |
| Cash And Cash Equivalents | $235,048,000 | $246,375,000 | $276,402,000 | $456,661,000 |
| Assets Held For Sale Current | - | - | - | - |
| Debt | ||||
| Net Debt | $1,621,058,000 | $1,556,718,000 | $1,223,147,000 | $986,654,000 |
| Total Debt | $2,033,184,000 | $1,984,563,000 | $1,681,682,000 | $1,615,359,000 |
| Long Term Debt And Capital Lease Obligation | $1,892,615,000 | $1,362,947,000 | $1,651,867,000 | $1,562,610,000 |
| Long Term Debt | $1,729,556,000 | $1,196,017,000 | $1,485,018,000 | $1,405,190,000 |
| Current Debt And Capital Lease Obligation | $140,569,000 | $621,616,000 | $29,815,000 | $52,749,000 |
| Current Debt | $126,550,000 | $607,076,000 | $14,531,000 | $38,125,000 |
| Other Current Borrowings | $126,550,000 | $607,076,000 | $14,531,000 | $38,125,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,558,538,000 | $2,492,144,000 | $2,194,104,000 | $2,085,355,000 |
| Total Non Current Liabilities Net Minority Interest | $2,102,557,000 | $1,570,018,000 | $1,887,124,000 | $1,764,449,000 |
| Other Non Current Liabilities | $204,278,000 | $146,238,000 | $199,940,000 | $138,501,000 |
| Non Current Deferred Liabilities | $5,664,000 | $60,833,000 | $35,317,000 | $63,338,000 |
| Non Current Deferred Taxes Liabilities | $5,664,000 | $60,833,000 | $35,317,000 | $63,338,000 |
| Current Liabilities | $455,981,000 | $922,126,000 | $306,980,000 | $320,906,000 |
| Current Deferred Liabilities | $11,463,000 | $10,483,000 | $8,540,000 | $7,253,000 |
| Payables And Accrued Expenses | $229,870,000 | $204,410,000 | $193,170,000 | $182,133,000 |
| Payables | $99,377,000 | $82,502,000 | $92,326,000 | $102,100,000 |
| Total Tax Payable | $3,651,000 | $0 | - | - |
| Income Tax Payable | $3,651,000 | $0 | - | - |
| Accounts Payable | $95,726,000 | $82,502,000 | $92,326,000 | $102,100,000 |
| Equity | ||||
| Common Stock Equity | $1,043,463,000 | $1,545,280,000 | $1,587,884,000 | $1,804,403,000 |
| Total Equity Gross Minority Interest | $1,043,463,000 | $1,545,280,000 | $1,587,884,000 | $1,804,403,000 |
| Stockholders Equity | $1,043,463,000 | $1,545,280,000 | $1,587,884,000 | $1,804,403,000 |
| Gains Losses Not Affecting Retained Earnings | $-30,077,000 | $-27,571,000 | $-15,106,000 | $10,265,000 |
| Other Equity Adjustments | $-30,077,000 | $-27,571,000 | $-15,106,000 | $10,265,000 |
| Retained Earnings | $423,441,000 | $939,915,000 | $946,859,000 | $879,118,000 |
| Other | ||||
| Treasury Shares Number | $14,399,000 | $14,445,000 | $12,751,000 | $6,823,000 |
| Ordinary Shares Number | $77,887,000 | $77,164,000 | $78,169,000 | $83,654,000 |
| Share Issued | $92,286,000 | $91,609,000 | $90,920,000 | $90,477,000 |
| Tangible Book Value | $-706,357,000 | $-759,260,000 | $-535,411,000 | $-361,087,000 |
| Invested Capital | $2,899,569,000 | $3,348,373,000 | $3,087,433,000 | $3,247,718,000 |
| Working Capital | $703,563,000 | $159,555,000 | $751,056,000 | $840,592,000 |
| Capital Lease Obligations | $177,078,000 | $181,470,000 | $182,133,000 | $172,044,000 |
| Total Capitalization | $2,773,019,000 | $2,741,297,000 | $3,072,902,000 | $3,209,593,000 |
| Treasury Stock | $689,210,000 | $691,411,000 | $647,262,000 | $362,862,000 |
| Additional Paid In Capital | $1,338,386,000 | $1,323,431,000 | $1,302,484,000 | $1,276,977,000 |
| Capital Stock | $923,000 | $916,000 | $909,000 | $905,000 |
| Common Stock | $923,000 | $916,000 | $909,000 | $905,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $163,059,000 | $166,930,000 | $166,849,000 | $157,420,000 |
| Current Deferred Revenue | $11,463,000 | $10,483,000 | $8,540,000 | $7,253,000 |
| Current Capital Lease Obligation | $14,019,000 | $14,540,000 | $15,284,000 | $14,624,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $74,079,000 | $85,617,000 | $75,455,000 | $78,771,000 |
| Current Accrued Expenses | $130,493,000 | $121,908,000 | $100,844,000 | $80,033,000 |
| Goodwill | $615,157,000 | $1,096,952,000 | $1,055,462,000 | $1,038,881,000 |
| Net PPE | $584,903,000 | $549,765,000 | $496,383,000 | $459,586,000 |
| Accumulated Depreciation | $-443,951,000 | $-396,923,000 | $-367,447,000 | $-329,729,000 |
| Gross PPE | $1,028,854,000 | $946,688,000 | $863,830,000 | $789,315,000 |
| Leases | $181,235,000 | $179,904,000 | $171,062,000 | $163,342,000 |
| Construction In Progress | $179,614,000 | $196,630,000 | $137,276,000 | $103,875,000 |
| Other Properties | $140,568,000 | $144,042,000 | $156,184,000 | $152,076,000 |
| Machinery Furniture Equipment | $444,973,000 | $405,412,000 | $383,471,000 | $354,346,000 |
| Buildings And Improvements | $78,308,000 | $19,748,000 | $14,859,000 | $14,710,000 |
| Land And Improvements | $4,156,000 | $952,000 | $978,000 | $966,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $262,614,000 | $223,729,000 | $196,402,000 | $172,088,000 |
| Work In Process | $99,348,000 | $79,423,000 | $74,035,000 | $70,598,000 |
| Raw Materials | $130,773,000 | $125,938,000 | $119,171,000 | $81,897,000 |
| Other Short Term Investments | $28,693,000 | $27,192,000 | $32,694,000 | $0 |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-45,254,000 | $15,011,000 | $73,090,000 | $217,384,000 |
| Operating Activities | ||||
| Operating Cash Flow | $50,384,000 | $129,382,000 | $139,955,000 | $264,469,000 |
| Cash Flow From Continuing Operating Activities | $50,384,000 | $129,382,000 | $139,955,000 | $264,469,000 |
| Operating Gains Losses | $490,000 | $1,496,000 | $777,000 | $-7,457,000 |
| Investing Activities | ||||
| Capital Expenditure | $-95,638,000 | $-114,371,000 | $-66,865,000 | $-47,085,000 |
| Investing Cash Flow | $-108,063,000 | $-390,808,000 | $-94,178,000 | $-58,580,000 |
| Cash Flow From Continuing Investing Activities | $-108,063,000 | $-390,808,000 | $-94,178,000 | $-58,580,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-221,000 | $-52,471,000 | $-275,000,000 | $-125,000,000 |
| Financing Cash Flow | $28,335,000 | $237,863,000 | $-229,925,000 | $-251,953,000 |
| Cash Flow From Continuing Financing Activities | $28,335,000 | $237,863,000 | $-229,925,000 | $-251,953,000 |
| Net Other Financing Charges | $-23,212,000 | $-15,433,000 | $-13,742,000 | $-24,618,000 |
| Net Common Stock Issuance | $-221,000 | $-52,471,000 | $-275,000,000 | $-125,000,000 |
| Other | ||||
| Repayment Of Debt | $-669,889,000 | $-187,131,000 | $-110,600,000 | $-148,550,000 |
| Issuance Of Debt | $720,700,000 | $486,500,000 | $165,100,000 | $40,750,000 |
| End Cash Position | $235,048,000 | $246,375,000 | $276,402,000 | $456,661,000 |
| Beginning Cash Position | $246,375,000 | $276,402,000 | $456,661,000 | $513,448,000 |
| Effect Of Exchange Rate Changes | $18,017,000 | $-6,464,000 | $3,889,000 | $-10,723,000 |
| Changes In Cash | $-29,344,000 | $-23,563,000 | $-184,148,000 | $-46,064,000 |
| Proceeds From Stock Option Exercised | $957,000 | $6,398,000 | $4,317,000 | $5,465,000 |
| Common Stock Payments | $-221,000 | $-52,471,000 | $-275,000,000 | $-125,000,000 |
| Net Issuance Payments Of Debt | $50,811,000 | $299,369,000 | $54,500,000 | $-107,800,000 |
| Net Long Term Debt Issuance | $50,811,000 | $299,369,000 | $54,500,000 | $-107,800,000 |
| Long Term Debt Payments | $-669,889,000 | $-187,131,000 | $-110,600,000 | $-148,550,000 |
| Long Term Debt Issuance | $720,700,000 | $486,500,000 | $165,100,000 | $40,750,000 |
| Net Investment Purchase And Sale | $-12,425,000 | $1,374,000 | $-27,313,000 | $4,909,000 |
| Sale Of Investment | $7,000,000 | $54,500,000 | $5,381,000 | $4,909,000 |
| Purchase Of Investment | $-19,425,000 | $-53,126,000 | $-32,694,000 | $0 |
| Net Business Purchase And Sale | $0 | $-277,811,000 | $0 | $-27,549,000 |
| Purchase Of Business | $0 | $-277,811,000 | $0 | $-51,509,000 |
| Net Intangibles Purchase And Sale | $-14,202,000 | $-9,953,000 | $0 | $-4,742,000 |
| Purchase Of Intangibles | $-14,202,000 | $-9,953,000 | $0 | $-4,742,000 |
| Net PPE Purchase And Sale | $-81,436,000 | $-104,418,000 | $-66,865,000 | $-31,198,000 |
| Purchase Of PPE | $-81,436,000 | $-104,418,000 | $-66,865,000 | $-42,343,000 |
| Change In Working Capital | $-33,736,000 | $-31,007,000 | $-81,574,000 | $-39,420,000 |
| Change In Other Working Capital | $3,400,000 | $3,540,000 | $128,000 | $4,274,000 |
| Change In Other Current Liabilities | $-17,156,000 | $-93,000 | $-410,000 | $-4,438,000 |
| Change In Other Current Assets | $3,343,000 | $-2,842,000 | $-8,535,000 | $-2,182,000 |
| Change In Payables And Accrued Expense | $26,724,000 | $-2,674,000 | $-20,229,000 | $17,343,000 |
| Change In Payable | $26,724,000 | $-2,674,000 | $-20,229,000 | $17,343,000 |
| Change In Account Payable | $26,724,000 | $-2,674,000 | $-20,229,000 | $17,343,000 |
| Change In Prepaid Assets | $-2,802,000 | $-8,187,000 | $2,652,000 | $8,612,000 |
| Change In Inventory | $-46,760,000 | $-28,149,000 | $-59,773,000 | $-29,124,000 |
| Change In Receivables | $-485,000 | $7,398,000 | $4,593,000 | $-33,905,000 |
| Changes In Account Receivables | $-485,000 | $7,398,000 | $4,593,000 | $-33,905,000 |
| Other Non Cash Items | $-15,412,000 | $9,089,000 | $21,241,000 | $-10,643,000 |
| Stock Based Compensation | $18,583,000 | $24,377,000 | $20,143,000 | $27,725,000 |
| Asset Impairment Charge | $511,365,000 | $12,209,000 | $0 | $0 |
| Deferred Tax | $-66,264,000 | $-20,731,000 | $-11,885,000 | $-4,585,000 |
| Deferred Income Tax | $-66,264,000 | $-20,731,000 | $-11,885,000 | $-4,585,000 |
| Depreciation Amortization Depletion | $151,832,000 | $140,893,000 | $123,512,000 | $118,299,000 |
| Depreciation And Amortization | $151,832,000 | $140,893,000 | $123,512,000 | $118,299,000 |
| Gain Loss On Sale Of PPE | $490,000 | $1,496,000 | $777,000 | $-6,813,000 |
| Net Income From Continuing Operations | $-516,474,000 | $-6,944,000 | $67,741,000 | $180,550,000 |
| Interest Paid Supplemental Data | - | $64,400,000 | $44,300,000 | $42,200,000 |
| Income Tax Paid Supplemental Data | - | $22,700,000 | $23,600,000 | $35,900,000 |
| Sale Of Business | - | $0 | $0 | $23,960,000 |
| Sale Of PPE | - | $0 | $0 | $11,145,000 |
| Gain Loss On Sale Of Business | - | $0 | $0 | $-644,000 |
Fetched: 2026-06-14